Jennifer King
Consultant / Advisor bei Ally Bridge Group HK Ltd
Profil
Jennifer King is currently working as an Advisor at Ally Bridge Group HK Ltd since 2022.
She previously worked as a Senior Director-Business Development at Shire Plc and as a Senior Vice President-Business Development at Intellia Therapeutics, Inc. She also served as an Independent Non-Executive Director at Exopharm Ltd.
from 2021 to 2023.
Dr. King holds an undergraduate degree from Massachusetts Institute of Technology, an MBA from Northeastern University, and a doctorate from Stanford University School of Medicine.
Aktive Positionen von Jennifer King
| Unternehmen | Position | Beginn |
|---|---|---|
Ally Bridge Group HK Ltd
 Ally Bridge Group HK Ltd Investment ManagersFinance Ally Bridge Group HK Ltd (Ally Bridge) is a private equity firm founded in 2011 by Frank Yu. The firm is headquartered in Hong Kong with additional office in the US. | Consultant / Advisor | 01.01.2022 |
Ehemalige bekannte Positionen von Jennifer King
| Unternehmen | Position | Ende |
|---|---|---|
| EXOPHARM | Director/Board Member | 22.02.2023 |
| SHIRE | Corporate Officer/Principal | - |
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Ausbildung von Jennifer King
| Massachusetts Institute of Technology | Undergraduate Degree |
| Northeastern University | Masters Business Admin |
| Stanford University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| EXOPHARM | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
Ally Bridge Group HK Ltd
Ally Bridge Group HK Ltd Investment ManagersFinance Ally Bridge Group HK Ltd (Ally Bridge) is a private equity firm founded in 2011 by Frank Yu. The firm is headquartered in Hong Kong with additional office in the US. | Finance |
